These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24295492)

  • 1. DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.
    Pinto R; De Summa S; Pilato B; Tommasi S
    Curr Mol Med; 2014 Jan; 14(1):45-57. PubMed ID: 24295492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer.
    Mathe A; Scott RJ; Avery-Kiejda KA
    Int J Mol Sci; 2015 Nov; 16(12):28347-76. PubMed ID: 26633365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.
    Rahman MM; Brane AC; Tollefsbol TO
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M
    Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation mechanisms of microRNA expression.
    Morales S; Monzo M; Navarro A
    Biomol Concepts; 2017 Dec; 8(5-6):203-212. PubMed ID: 29161231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular Medicine.
    Ray SK; Mukherjee S
    Curr Mol Med; 2022; 22(10):835-850. PubMed ID: 34872474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-135b Contributes to
    Uva P; Cossu-Rocca P; Loi F; Pira G; Murgia L; Orrù S; Floris M; Muroni MR; Sanges F; Carru C; Angius A; De Miglio MR
    Int J Med Sci; 2018; 15(6):536-548. PubMed ID: 29725243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
    Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
    Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
    Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
    Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
    Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression.
    Chang S; Sharan SK
    Transcription; 2013; 4(1):24-8. PubMed ID: 23131665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetics of breast cancer.
    Jovanovic J; Rønneberg JA; Tost J; Kristensen V
    Mol Oncol; 2010 Jun; 4(3):242-54. PubMed ID: 20627830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual regulation of microRNAs and DNA methylation in human cancers.
    Wang S; Wu W; Claret FX
    Epigenetics; 2017 Mar; 12(3):187-197. PubMed ID: 28059592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.
    Gao S; Wang Y; Wang M; Li Z; Zhao Z; Wang RX; Wu R; Yuan Z; Cui R; Jiao K; Wang L; Ouyang L; Liu R
    Oncotarget; 2017 Jun; 8(25):41451-41464. PubMed ID: 28562349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.